Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Seeks to Raise $6.8M in Private Placement

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix said after the close of the market on Monday that it has entered into a securities purchase agreement to sell almost $6.8 million of newly issued shares.

The firm will sell a combination of common stock and warrants in a private placement to accredited investors.

Net proceeds from the transaction will be used to fund growth initiatives and for general working capital purposes.

Under the terms of the agreement, CombiMatrix will sell 3.08 million units for about $2.19 per unit, with each unit consisting of one share of the company's common stock and one warrant to purchase .425 shares of common stock at an exercise price of $2.14 per share.

The unit price reflects the market value of CombiMatrix's stock, as determined by Nasdaq rules, plus about $.05 for the warrant component. The warrants are exercisable six months after the closing date and have a term of five years.

The transaction is expected to close on April 7.

A year ago this month, CombiMatrix restructured its business to preserve cash and increase its focus on its diagnostics services business.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.